Hydroxyurea 500
Drug Category |
|
Medicinal form |
Capsules |
Active ingredient |
|
Concentration |
500mg |
Manufacturer |
|
Price |
260 EGP |
Uses
Action CaUses cell death by specific inhibition of DNA symthesis. This action caUses regressions in chronic myeloid leukemia and other malignancies and psoriasis. The S-phase-specific action of hydroxyurea can deplete bone marrow precursor cells associated with megaloblastic changes.
Dosage:Adults : Solid tumours Intermittent therapy : 80 mg/kg as single dose every 3 rd day. Continuous therapy : 20-30 mg/kg as single daily Dose Carcinoma of head and neck : 80 mg/kg as a single dose every Yd day. Begin therapy atleast 7 days before initiation of irradiation therapy. Resistant chronic myelocytic leukaemia : Continuous therapy of 20-30 mg/kg as a single daily Dose is recommended.
Note: The information provided about this drug does not substitute for consulting a doctor.
Direct Access to Pharmacy Through Innovative Portal
Empower your health journey with Direct Access to Pharmacy Through Innovative Portal - Your gateway to seamless and efficient healthcare solutions at your fingertips
See list pharmacies